Tpharm.info


Lovenox package insert





Lovenox (enoxaparin sodium injection) for subcutaneous and

12/19/2014
03:13 | Author: Nick Jenkins

Lovenox package insert
Lovenox (enoxaparin sodium injection) for subcutaneous and

These highlights do not include all the information needed to use Lovenox safely and Lovenox is a low molecular weight heparin [LMWH] indicated for:.

Abdominal Surgery: In patients undergoing abdominal surgery who are at risk for thromboembolic complications, the recommended dose of Lovenox is 40 mg once a day administered by SC injection with the initial dose given 2 hours prior to surgery. The usual duration of administration is 7 to 10 days; up to 12 days administration has been administered in clinical trials.

Treatment of Acute ST-Segment Elevation Myocardial Infarction: In patients with acute ST-segment elevation myocardial infarction, the recommended dose of Lovenox is a single IV bolus of 30 mg plus a 1 mg/kg SC dose followed by 1 mg/kg administered SC every 12 hours (maximum 100 mg for the first two doses only, followed by 1 mg/kg dosing for the remaining doses).

Comments (1)Read more



LOVENOX- Treatment for Deep Vein Thrombosis (DVT) Blood Clots

10/18/2014
01:34 | Author: Lauren Ross

Lovenox package insert
LOVENOX- Treatment for Deep Vein Thrombosis (DVT) Blood Clots

It was inserted, and release. syringe is empty. others, and push down on. syringe and discard it in the. Insert the full length of the. the skin fold. sharps collector.

Most patients or caregivers can administer LOVENOX injections after learning how to properly inject it. Review and follow all the steps outlined below to ensure proper administration and safe disposal of LOVENOX prefilled syringes. Be sure to discuss these steps with your doctor before you administer LOVENOX for the first time.

Some patients on LOVENOX can experience drops in their plaet counts, a condition called "thrombocytopenia." Also, a serious but rare condition called "heparin-induced thrombocytopenia" can occur with LOVENOX.

Comments (2)Read more

DailyMed - LOVENOX - enoxaparin sodium injection

8/17/2014
01:01 | Author: Nick Jenkins

Lovenox package insert
DailyMed - LOVENOX - enoxaparin sodium injection

Label: LOVENOX - enoxaparin sodium injection. Label RSS; Share. : JavaScript needed for Sharing tools. Bookmark & View Package Photos. Package Photo.

Consider the benefits and risks before neuraxial intervention in patients anticoagulated or to be anticoagulated for thromboprophylaxis [see Warnings and Precautions (5.1) and Drug Interactions (7) ]

Lovenox is indicated for the prophylaxis of ischemic complications of unstable angina and non-Q-wave myocardial infarction, when concurrently administered with aspirin.

All patients should be evaluated for a bleeding disorder before administration of Lovenox, unless the medication is needed urgently. Since coagulation parameters are unsuitable for monitoring Lovenox activity, routine monitoring of coagulation parameters is not required.

The use of Lovenox for thromboprophylaxis in pregnant women with mechanical prosthetic heart valves has not been adequay studied.

Comments (3)Read more

Lovenox (Cardinal Health) FDA Package Insert

6/16/2014
03:12 | Author: David Perry

Lovenox package insert
Lovenox (Cardinal Health) FDA Package Insert

Cardinal Health: Lovenox is a low molecular weight heparin [LMWH] indicated for: 1 Prophylaxis of deep vein thrombosis (DVT) in abdominal.

For patients managed with percutaneous coronary intervention (PCI): If the last Lovenox SC administration was given less than 8 hours before balloon inflation, no additional dosing is needed. If the last Lovenox SC administration was given more than 8 hours before balloon inflation, an IV bolus of 0.3 mg/kg of Lovenox should be administered.

Hip or Knee Replacement Surgery: In patients undergoing hip or knee replacement surgery, the recommended dose of Lovenox is 30 mg every 12 hours administered by SC injection.

Comments (4)Read more

Enoxaparin Sodium (Winthrop U.S.) FDA Package Insert

4/15/2014
05:05 | Author: Kayla Henderson

Lovenox package insert
Enoxaparin Sodium (Winthrop U.S.) FDA Package Insert

Winthrop U.S.: Enoxaparin sodium is a low molecular weight heparin [LMWH] indicated for: Prophylaxis of deep vein thrombosis (DVT) in.

Epidural or spinal hematomas may occur in patients who are anticoagulated with low molecular weight heparins (LMWH) or heparinoids and are receiving neuraxial anesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis. Consider these risks when scheduling patients for spinal procedures. Factors that can increase the risk of developing epidural or spinal hematomas in these patients include:

Treatment of Acute ST-Segment Elevation Myocardial Infarction: In patients with acute ST-segment elevation myocardial infarction, the recommended dose of enoxaparin sodium is a single IV bolus of 30 mg plus a 1 mg/kg SC dose followed by 1 mg/kg administered SC every 12 hours (maximum 100 mg for the first two doses only, followed by 1 mg/kg dosing for the remaining doses).

Comments (5)Read more